Immune activation following cytomegalovirus infection: More important than direct viral effects in cardiovascular disease?

Journal of Clinical Virology

Volumn 35, Issue 3, 2006, Pages 349-353

  Stassen, Frank R ^a   Vega Córdova, Xavier ^a   Vliegen, Inge ^a   Bruggeman, Cathrien A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Cardiovascular; Cytomegalovirus

Indexed keywords

CYTOKINE; OXIDIZED LOW DENSITY LIPOPROTEIN; TOLL LIKE RECEPTOR;

ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CELL ADHESION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HERPES VIRUS; IMMUNOREACTIVITY; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REVIEW; SEROEPIDEMIOLOGY; VASCULAR DISEASE; VASCULAR LESION;

EID: 31944448471     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2005.11.007     Document Type: Article

References (52)

1. S. Akira, and K. Takeda Toll-like receptor signaling Nat Rev Immunol 4 7 2004 499 511
2. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat Immunol 2 8 2001 675 680
3. G.D. Almeida, C.D. Porada, S. St Jeor, and J.L. Ascensao Human cytomegalovirus alters interleukin-6 production by endothelial cells Blood 83 1994 370 376
4. C. Bason, R. Corrocher, C. Lunardi, P. Puccetti, O. Olivieri, and D. Girelli Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis Lancet 362 9400 2003 1971 1977
5. K. Berencsi, V. Endresz, D. Klurfeld, L. Kari, D. Kritchevsky, and E. Gonczol Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice Cell Adhes Commun 5 1998 39 47
6. A. Blum, M. Giladi, M. Weinberg, G. Kaplan, H. Pasternack, and S. Laniado High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis Am J Cardiol 81 1998 866 868
7. A.G. Bowie, and I.R. Haga The role of Toll-like receptors in the host response to viruses Mol Immunol 42 8 2005 859 867
8. L.A. Campbell, and C.C. Kuo Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2 1 2004 23 32
9. B. Chiu, E. Viira, W. Tucker, and I.W. Fong Chlamydia pneumoniae, cytomegalovirus, and Herpes simplex virus in atherosclerosis of the carotid artery Circulation 96 1997 2144 2148
10. T. Compton, E.A. Kurt-Jones, K.W. Boehme, J. Belko, E. Latz, and D.T. Golenbock Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2 J Virol 77 8 2003 4588 4596
11. J. Danesh, R. Collins, and R. Peto Chronic infections and coronary heart disease: is there a link? Lancet 350 1997 430 436
12. H. Daus, C. Ozbek, D. Saage, B. Scheller, H. Schieffer, and M. Pfreundschuh Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation Cardiology 90 1998 83 88
13. K. Edfeldt, J. Swedenborg, G.K. Hansson, and Z.Q. Yan Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation Circulation 105 10 2002 1158 1161
14. S.E. Epstein, E. Speir, Y.F. Zhou, E. Guetta, M. Leon, and T. Finkel The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus Lancet 348 Suppl. 1 1996 s13 s17
15. C. Espinola-Klein, H.J. Rupprecht, S. Blankenberg, C. Bickel, H. Kopp, and G. Rippin AtheroGene investigators. Impact of infectious burden on extent and long-term prognosis of atherosclerosis Circulation 105 1 2002 15 21
16. C.G. Fabricant, J. Fabricant, M.M. Litrenta, and C.R. Minick Virus-induced atherosclerosis J Exp Med 148 1978 335 340
17. D. Fairweather, S. Frisancho-Kiss, and N.R. Rose Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis Rev Med Virol 15 1 2005 17 27
18. E. Faure, L. Thomas, H. Xu, A. Medvedev, O. Equils, and M. Arditi Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation J Immunol 166 3 2001 2018 2024
19. S. Frantz, L. Kobzik, Y.D. Kim, R. Fukazawa, R. Medzhitov, and R.T. Lee Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium J Clin Invest 104 3 1999 271 280
20. M. Gattone, L. Iacoviello, M. Colombo, A.D. Castelnuovo, F. Soffiantino, and A. Gramoni Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age Am Heart J 142 2001 633 640
21. A.E. Gharavi, S.S. Pierangeli, and E.N. Harris Viral origin of antiphospholipid antibodies: endothelial cell activation and thrombus enhancement by CMV peptide-induced APL antibodies Immunobiology 207 1 2003 37 42
22. M.T. Grattan, C.E. Moreno Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis JAMA 261 1989 3561 3566
23. M. Hallman, M. Ramet, and R.A. Ezekowitz Toll-like receptors as sensors of pathogens Pediatr Res 50 3 2001 315 321
24. M.G. Hendrix, M.M. Salimans, C.P. van Boven, and C.A. Bruggeman High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis Am J Pathol 136 1990 23 28
25. E. Hsich, Y.F. Zhou, B. Paigen, T.M. Johnson, M.S. Burnett, and S.E. Epstein Cytomegalovirus infection increases development of atherosclerosis in apolipoprotein-E knockout mice Atherosclerosis 156 2001 23 28
26. G.B. Johnson, G.J. Brunn, and J.L. Platt Activation of mammalian Toll-like receptors by endogenous agonists Crit Rev Immunol 23 1-2 2003 15 44
27. R.S. Kalil, S.L. Hudson, and R.S. Gaston Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus? Am J Transplant 3 2003 79 81
28. D.A. Knight, W.J. Waldman, and D.D. Sedmak Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells Transplantation 68 1999 1814 1818
29. S.R. Krutzik, B. Tan, H. Li, M.T. Ochoa, P.T. Liu, and S.E. Sharfstein TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells Nat Med 11 6 2005 653 660
30. M. Leinonen, and P. Saikku Evidence for infectious agents in cardiovascular disease and atherosclerosis Lancet Infect Dis 2 1 2002 11 17
31. J.L. Melnick, B.L. Petrie, G.R. Dreesman, J. Burek, C.H. McCollum, and M.E. DeBakey Cytomegalovirus antigen within human arterial smooth muscle cells Lancet 2 1983 644 647
32. M.M. Monick, T.O. Yarovinsky, L.S. Powers, N.S. Butler, A.B. Carter, and G. Gudmundsson Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin J Biol Chem 278 52 2003 53035 53044
33. F.J. Nieto, E. Adam, P. Sorlie, H. Farzadegan, J.L. Melnick, and G.W. Comstock Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis Circulation 94 1996 922 927
34. S. O'Connor, C. Taylor, L.A. Campbell, S. Epstein, and P. Libby Potential infectious etiologies of atherosclerosis: a multifactorial perspective Emerg Infect Dis 7 5 2001 780 788
35. V. Pengo, A. Zocche, R. Scognamiglio, A. Biasiolo, T. Del Ros, and A. Ruffatti Accelerated atherosclerosis in the aortic arch and cerebral ischemia in a patient with primary antiphospholipid syndrome Y. Shoenfeld D. Harats G. Wick Atherosclerosis and Autoimmunity 2001 Elsevier Science B.V. Amsterdam 297 300
36. B.L. Petrie, J.L. Melnick, E. Adam, J. Burek, C.H. McCollum, and M.E. DeBakey Nucleic acid sequences of cytomegalovirus in cells cultured from human arterial tissue J Infect Dis 155 1987 158 159
37. P.W. Radke, S. Merkelbach-Bruse, B.J. Messmer, J. vom Dahl, H. Dorge, and A. Naami Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, co-infection, and clinical findings Coron Artery Dis 12 1 2001 1 6
38. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, and C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
39. A. Saetta, G. Fanourakis, E. Agapitos, and P.S. Davaris Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation Cardiovasc Pathol 9 3 2000 181 183
40. P. Saikku, M. Leinonen, K. Mattila, M.R. Ekman, M.S. Nieminen, and P.H. Makela Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction Lancet 2 8618 1988 983 986
41. P.D. Smith, S.S. Saini, M. Raffeld, J.F. Manischewitz, and S.M. Wahl Cytomegalovirus induction of tumor necrosis factor-alpha by human monocytes and mucosal macrophages J Clin Invest 90 1992 1642 1648
42. D.N. Streblow, L. Susan, S.L. Orloff, and J.A. Nelson Do pathogens accelerate atherosclerosis? J Nutr 131 2001 2798S 2804S
43. K. Takeda, T. Kaisho, and S. Akira Toll-like receptors Annu Rev Immunol 21 2003 335 376
44. M.F. Tsan, and B. Gao Endogenous ligands of Toll-like receptors J Leukoc Biol 76 3 2004 514 519
45. S.A. Vaidya, and G. Cheng Toll-like receptors and innate antiviral responses Curr Opin Immunol 15 4 2003 402 407
46. I. Vliegen, A. Duijvestijn, G. Grauls, S. Herngreen, C. Bruggeman, and F. Stassen Cytomegalovirus infection aggravates atherogenesis in apoE knockout mice by both local and systemic immune activation Microbes Infect 6 1 2004 17 24
47. I. Vliegen, S.B. Herngreen, G.E. Grauls, C.A. Bruggeman, and F. Stassen Mouse cytomegalovirus antigenic immune stimulation is sufficient to aggravate atherosclerosis in hypercholesterolemic mice Atherosclerosis 181 1 2005 39 44
48. I. Vliegen, F. Stassen, G. Grauls, R. Blok, and C. Bruggeman MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice J Clin Virol 25 Suppl. 2 2002 S159 S171
49. S.B. Woodroffe, H.M. Garnett, and V.A. Danis Interleukin-1 production and cell-activation response to cytomegalovirus infection of vascular endothelial cells Arch Virol 133 1993 295 308
50. Y.F. Zhou, E. Guetta, Z.X. Yu, T. Finkel, and S.E. Epstein Human cytomegalovirus increases modified low-density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells J Clin Invest 98 1996 2129 2138
51. Y.F. Zhou, M.B. Leon, M.A. Waclawiw, J.J. Popma, Z.X. Yu, and T. Finkel Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy N Engl J Med 335 9 1996 624 630
52. Y.F. Zhou, Z.X. Yu, C. Wanishsawad, M. Shou, and S.E. Epstein The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor Biochem Biophys Res Commun 256 1999 608 613